The impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non‐small cell lung cancer: A meta‐analysis
Abstract Background Previous studies have suggested that loss of the EGFR T790M gene mutation may contribute to the development of resistance to Osimertinib in non‐small cell lung cancer (NSCLC). Aims This study aims to assess the relationship between the clinical effectiveness of Osimertinib in NSC...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wiley
2024-04-01
|
| Serie: | The Clinical Respiratory Journal |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1111/crj.13748 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|